Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ellison

Showing results (81-90 of 692) with videos related to

Pageof 70
Sort By:
The American Journal of Psychiatry|January 1, 1984
A case of severe acute desipramine overdoseW T Sawyer, J L Caudill, M J Ellison
British Medical Journal|August 31, 1974
Oral contraceptives and increased formation of soluble fibrinL O Pilgeram, J Ellison, G Von dem Bussche
The Journal of Chemical Physics|August 22, 2024
Equilibrium phase behavior of gyroid-forming diblock polymer thin filmsBenjamin R Magruder, Christopher J Ellison, Kevin D Dorfman
The Journal of Endocrinology|April 1, 1988
Only tissue-type plasminogen activator is secreted by immature bovine Sertoli cell-enriched culturesR J Coombs, J Ellison, A Woods, et al.
In Silico Biology|June 24, 2005
A life-like virtual cell membrane using discrete automataGordon Broderick, Melania Ru'aini, Eugene Chan, et al.
The Journal of Biological Chemistry|May 5, 1992
Expression of a ubiquitin derivative that conjugates to protein irreversibly produces phenotypes consistent with a ubiquitin deficiencyR R Hodgins, K S Ellison, M J Ellison
Journal of Biomolecular NMR|May 29, 2000
Letter to the editor: 1H, 15N and 13C resonance assignments for the catalytic domain of the yeast E2, UBC1K S Hamilton, M J Ellison, G S Shaw
Physical Review Letters|October 2, 2009
Time's barbed arrow: irreversibility, crypticity, and stored informationJames P Crutchfield, Christopher J Ellison, John R Mahoney
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1991
The short-lived MAT alpha 2 transcriptional regulator is ubiquitinated in vivoM Hochstrasser, M J Ellison, V Chau, et al.
Vaccine|August 4, 2020
VaxiPatch™, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017Thomas J Ellison, George C Talbott, Daniel R Henderson
Pageof 70

Showing results (81-90 of 692) with videos related to

Sort By:
Pageof 70
The American Journal of Psychiatry|January 1, 1984
A case of severe acute desipramine overdoseW T Sawyer, J L Caudill, M J Ellison
British Medical Journal|August 31, 1974
Oral contraceptives and increased formation of soluble fibrinL O Pilgeram, J Ellison, G Von dem Bussche
The Journal of Chemical Physics|August 22, 2024
Equilibrium phase behavior of gyroid-forming diblock polymer thin filmsBenjamin R Magruder, Christopher J Ellison, Kevin D Dorfman
The Journal of Endocrinology|April 1, 1988
Only tissue-type plasminogen activator is secreted by immature bovine Sertoli cell-enriched culturesR J Coombs, J Ellison, A Woods, et al.
In Silico Biology|June 24, 2005
A life-like virtual cell membrane using discrete automataGordon Broderick, Melania Ru'aini, Eugene Chan, et al.
The Journal of Biological Chemistry|May 5, 1992
Expression of a ubiquitin derivative that conjugates to protein irreversibly produces phenotypes consistent with a ubiquitin deficiencyR R Hodgins, K S Ellison, M J Ellison
Journal of Biomolecular NMR|May 29, 2000
Letter to the editor: 1H, 15N and 13C resonance assignments for the catalytic domain of the yeast E2, UBC1K S Hamilton, M J Ellison, G S Shaw
Physical Review Letters|October 2, 2009
Time's barbed arrow: irreversibility, crypticity, and stored informationJames P Crutchfield, Christopher J Ellison, John R Mahoney
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1991
The short-lived MAT alpha 2 transcriptional regulator is ubiquitinated in vivoM Hochstrasser, M J Ellison, V Chau, et al.
Vaccine|August 4, 2020
VaxiPatch™, a novel vaccination system comprised of subunit antigens, adjuvants and microneedle skin delivery: An application to influenza B/Colorado/06/2017Thomas J Ellison, George C Talbott, Daniel R Henderson
Pageof 70